Replimune REPL
NASDAQ REPL
$11.80 +0.38 (+3.33%)
As of: Oct 21, 2026 · 1:29 PM EDT

Replimune (REPL) FCF Margin (2017 - 2018)

Updated

Analysis

Replimune (REPL) FCF Margin (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,134.69 Bn 1,103.27 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 616.29 Bn 534.82 Bn 17.26 Bn 28.82%
3 AbbVie 500.86 Bn 473.97 Bn 12.70 Bn 18.33%
4 Merck 366.77 Bn 321.15 Bn 12.21 Bn 26.96%
5 Novartis Ag 297.69 Bn 261.68 Bn 11.24 Bn 38.60%
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn 6.55%
7 Amgen 235.52 Bn 190.92 Bn 7.24 Bn 34.70%
8 Gilead Sciences 190.49 Bn 164.69 Bn 6.22 Bn 44.00%
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn 2.01%
10 Replimune 1.14 Bn 87.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -763.72%
Sep 30, 2018 -961.75%
Jun 30, 2018 -3,072.69%
Dec 31, 2017 -8,440.63%
Sep 30, 2017 -36,940.00%
Jun 30, 2017 -18,420.00%
API Access

Replimune FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=REPL&period=max&api_key=YOUR_API_KEY